Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486427 | SCV000570075 | likely pathogenic | not provided | 2016-06-15 | criteria provided, single submitter | clinical testing | The S687R variant a has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. S687R is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a protein position that is conserved across species. In silico analysis predicts S687R creates a new strong cryptic splice donor site upstream of the natural donor site in exon 20, which remains unchanged. Missense variants in nearby residues (L683P, F684C, A689D) have been reported in the Human Gene Mutation Database in association with X-linked hypophosphatemic rickets (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |